[ad_1] Wall Street finished higher for the holiday-shortened trading week, with tech stocks leading the way.…
Tag: Jim Cramer
FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…
The 4 key things we’re watching in the stock market this holiday-shortened week
[ad_1] The Nasdaq Composite inched higher Friday to claim its fifth straight record close, as new…
Here are 9 stocks that can benefit from Fed interest rate cuts
[ad_1] The S & P 500 and Nasdaq extended their record rallies this week following cooler-than-expected…
Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks
[ad_1] Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing…
Jim Cramer says Nike should watch its back with Hoka running shoes doing so well
[ad_1] CNBC’s Jim Cramer sees footwear company Deckers Outdoor as a disruptive industry player that even…
Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…
We’re encouraged by an activist’s willingness to buy an Abbott rival, look past baby formula suits
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…
Here are the portfolio’s top 5 performers in a record-setting week for stocks
[ad_1] The bulls got what they wanted this week: cooler inflation data and record highs. The…
Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock
[ad_1] Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea —…
Abbott Labs’ surprise guidance bump is a major positive for its shareholders
[ad_1] Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising…
Health care has had a tough year. Where we stand on our 5 stocks in the sector
[ad_1] There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe…
This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock
[ad_1] Medical equipment giant Danaher (DHR) will officially spin off its environmental-and-applied solutions segment later this…
Here are the 8 trades and 3 price-target changes we made during a busy week
[ad_1] Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly…